Description
Obagi-C Rx C-Therapy Night Cream gradually diminishes dark spots with 4% hydroquinone while providing vitamins C and E to nourish the skin overnight. This prescription-strength formula promotes skin rejuvenation from within, helping to reduce hyperpigmentation and age spots. The inclusion of 10% L-ascorbic acid (vitamin C) helps stimulate collagen production and protects against future skin damage.
Key Ingredients
- Hydroquinone 4%: A potent inhibitor of melanin production, helping to reduce and potentially eliminate melasma.
- L-Ascorbic Acid (Vitamin C) 10%: A powerful antioxidant known to boost collagen synthesis and protect skin from oxidative stress.
Full Ingredients
Water (Aqua), Glycerin, Cetyl Alcohol, PPG-2 Myristyl Ether Propionate, Sodium Lauryl Sulfate, TEA-Salicylate, Lactic Acid, Phenyl Trimethicone, Tocopheryl Acetate (Vitamin E), Sodium Metabisulfite, Ascorbic Acid (Vitamin C), Methylparaben, Disodium EDTA, Propylparaben, Saponins, BHT.
Safety Information
Contraindications:
- Individuals with a history of sensitivity or allergic reactions to any of the ingredients should not use this product.
- The safety of hydroquinone during pregnancy or in children under 12 years of age has not been established.
Warnings:
- Avoid contact with eyes, nose, mouth, or lips. If accidental contact occurs, rinse immediately with water and seek medical advice.
- Sunscreen is essential during hydroquinone treatment, as even minimal sun exposure can sustain melanin production.
- Contains sodium metabisulfite, which may trigger allergic reactions, including severe asthmatic episodes in susceptible individuals.
Precautions:
- Apply to small areas initially, as some users may experience mild redness or burning sensations.
- Pregnancy & Nursing: Hydroquinone falls under Pregnancy Category C, meaning its effects on fetal development are unknown. It should only be used during pregnancy if clearly necessary. Its absorption into breast milk is also unknown, so nursing mothers should use caution.
- Pediatric Use: The safety and effectiveness of this product in children under 12 years have not been established.
